Opportunities In Fertility: Recognizing Gaps In The Market

Ferring Pharmaceuticals’ US CSO Elizabeth Garner talks to In Vivo about the future of fertility and where investment should be heading to make a dent in this multi-million-dollar market.

market gap
Highlighting the gaps in fertility and women's health • Source: Shutterstock

At a time when the biopharma industry is still suffering from the financing hangover of 2022, investment in women’s health is on the upswing.

While company founders, investors and scientists have been discussing the state of investment, or lack thereof, in women’s health for many years, it seems that the wider investment community has...

More from Growth

More from In Vivo